Top compounds associated with response to NRDC


Feature Type Standardized
Nominal ANOVA
mRNA Zebularine CTRPv2 pan-cancer AAC -0.027 0.4
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.028 0.4
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.04 0.4
mRNA Erlotinib gCSI pan-cancer AAC 0.049 0.5
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.041 0.5
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.5
mRNA BI-2536 FIMM pan-cancer AAC -0.097 0.5
mRNA GDC-0941 GDSC1000 pan-cancer AAC 0.027 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.5
Download CSV